- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Akari Therapeutics PLC (AKTX)Akari Therapeutics PLC stock price live, this page displays NASDAQ AKTX stock exchange data. View the AKTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Akari Therapeutics PLC real time stock price chart below.
What Is the Akari Therapeutics PLC Stock Price Today?
The Akari Therapeutics PLC stock price today is 1.3214.
What Is the Stock Symbol for Akari Therapeutics PLC?
The stock symbol for Akari Therapeutics PLC is "AKTX."
What Stock Exchange Does Akari Therapeutics PLC Trade On?
Akari Therapeutics PLC is listed and trades on the NASDAQ stock exchange.
Is Akari Therapeutics PLC a Good Stock to Buy?
Determining whether Akari Therapeutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AKTX quote. (ISIN: US00972G2075)
What Is the Akari Therapeutics PLC Stock Price Today?
The Akari Therapeutics PLC stock price today is 1.3214.
What Is the Stock Symbol for Akari Therapeutics PLC?
The stock symbol for Akari Therapeutics PLC is "AKTX."
What Stock Exchange Does Akari Therapeutics PLC Trade On?
Akari Therapeutics PLC is listed and trades on the NASDAQ stock exchange.
Is Akari Therapeutics PLC a Good Stock to Buy?
Determining whether Akari Therapeutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AKTX quote. (ISIN: US00972G2075)
NASDAQ
Currency in USD
1.3214
+0.0314(+2.43%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1938
1.4000
52 wk Range
0.9000
4.4000
AKTX Scorecard
Full Analysis
Significant return over the last week
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.19381.4000
52 wk Range
0.90004.4000
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockAKTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Akari Therapeutcis Regains Nasdaq Compliance
- Investing.com
- Akari Therapeutics appoints Rob Bazemore to board
- Investing.com
- Akari Therapeutcis Regains Nasdaq Compliance
- Investing.com
Akari Therapeutics PLC Company Profile
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.
Compare AKTX to Peers and Sector
Metrics to compare | AKTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAKTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | −3.3x | −0.7x | |
PEG Ratio | 0.07 | 0.13 | 0.00 | |
Price/Book | −4.8x | 2.4x | 2.6x | |
Price / LTM Sales | - | 25.7x | 3.2x | |
Upside (Analyst Target) | - | 159.4% | 46.4% | |
Fair Value Upside | Unlock | 7.8% | 6.9% | Unlock |
People Also Watch
FAQ
What Is the Akari Therapeutics (AKTX) Stock Price Today?
The Akari Therapeutics stock price today is 1.3214
What Stock Exchange Does Akari Therapeutics Trade On?
Akari Therapeutics is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Akari Therapeutics?
The stock symbol for Akari Therapeutics is "AKTX."
What Is the Akari Therapeutics Market Cap?
As of today, Akari Therapeutics market cap is 31.94M.
What is Akari Therapeutics Earnings Per Share?
The Akari Therapeutics EPS is -2.46.
From a Technical Analysis Perspective, Is AKTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.